MedTrace Logo

Change in LVEF Following Transcatheter Mitral Edge-To-Edge Repair

NCT05311163 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2022-04-05

No results posted yet for this study

Summary

Little is known regarding the impact of transcatheter mitral valve edge-to-edge repair (TEER) on the acute changes in left ventricular ejection fraction (LVEF) and the effect of an acute reduction in LVEF, the so-called "afterload mismatch" (AM), on prognosis.

We thereby aim to assess changes in LVEF after TEER, identify rate and predictors AM, and estimate its impact on prognosis.

Conditions

  • Mitral Regurgitation

Interventions

PROCEDURE

MitraClip

Transcatheter Mitral Edge-To-Edge Repair

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Eligibility

Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-08-01
Completion
2022-08-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05311163 on ClinicalTrials.gov